Pfizer reports strong Q1 earnings, including $18.3B in revenues

Pfizer generated $18.3 billion in quarterly revenues, well exceeding Wall Street estimates, according to its latest earnings report released Tuesday morning.

Despite an expected slide in demand for its COVID-19 vaccine Comirnaty and oral antiviral Paxlovid, the drugmaker benefited from $7.1 billion in revenue from those two products.